+关注
TasteB
暂无个人介绍
IP属地:未知
9
关注
0
粉丝
0
主题
0
勋章
主贴
热门
TasteB
2020-05-06
高
@价值投资为王:沛嘉医疗:镶在高端医疗器械桂冠上的明珠
TasteB
2020-04-22
A and B
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3516231728412349","uuid":"3516231728412349","gmtCreate":1553137706756,"gmtModify":1553137706756,"name":"TasteB","pinyin":"tasteb","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":9,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.91%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.94%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":927398930,"gmtCreate":1588736502120,"gmtModify":1704178222420,"author":{"id":"3516231728412349","authorId":"3516231728412349","name":"TasteB","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3516231728412349","idStr":"3516231728412349"},"themes":[],"htmlText":"高","listText":"高","text":"高","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/927398930","repostId":"927391874","repostType":1,"repost":{"id":927391874,"gmtCreate":1588736312783,"gmtModify":1704178221726,"author":{"id":"21347731130544","authorId":"21347731130544","name":"价值投资为王","avatar":"https://static.tigerbbs.com/89ffffc59ff9ac9cb9cb74f596418d44","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"21347731130544","idStr":"21347731130544"},"themes":[],"title":"沛嘉医疗:镶在高端医疗器械桂冠上的明珠","htmlText":"本周五上市的生物科技热门股<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a>高开74.48%,现在上车晚不晚? 对于医疗器械,大家并不陌生,小到体温计、血压仪,大到呼吸机、核磁共振器,医疗器械成为人类生命健康不可或缺的产业。 而高端医疗器械更是集合了生物工程、电子信息和医学影像等高新技术,是知识密集型、资金密集型的战略新兴产业。 目前,我国的高端医疗器械市场大部分仍被外资垄断,但在经导管瓣膜治疗领域,国内产品是少有的处于垄断地位的行业。 今天的主角,正处于招股期的<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a> 即是此领域的重磅玩家。 人工心脏瓣膜,医疗器械界的“网红” 每个人的心脏都有四个瓣膜,分别是主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣,正常运作的瓣膜可以确保适当的血液流动,而当其中的一个或多个瓣膜出现损伤或缺陷的时候,如瓣膜太窄或硬化,无法正常的开启或闭合,就会造成血液反流,轻者会感到乏力、呼吸困难、眩晕,重者会引发心绞痛,血栓栓塞和心脏衰竭,是死亡率极高的病种。 目前,治疗主动脉瓣疾病的方案主要是传统的开胸手术,手术切口在18cm左右,不仅复杂和费用高昂,术后并发症也较为严重,一般只有到了危重期才会采用。 到了2002年,经导管主动脉瓣置换术(TAVR)在法国进行了首次治疗,其无需开胸、通过血管路径植入人工心脏瓣膜,不仅创伤小,而且恢复快,迅速成为新一代治疗方案,引得诸多国际大厂争相涌入,人工心脏瓣膜迅速成为医疗器械界的“网红”。 (人工主动脉瓣说明图) 在国际上,爱德华兹和美敦力占据了市场的主要份额。在国内,抢先一步上市的启明医疗占据了主要的份额,根据招股书披露,2018年,启明医","listText":"本周五上市的生物科技热门股<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a>高开74.48%,现在上车晚不晚? 对于医疗器械,大家并不陌生,小到体温计、血压仪,大到呼吸机、核磁共振器,医疗器械成为人类生命健康不可或缺的产业。 而高端医疗器械更是集合了生物工程、电子信息和医学影像等高新技术,是知识密集型、资金密集型的战略新兴产业。 目前,我国的高端医疗器械市场大部分仍被外资垄断,但在经导管瓣膜治疗领域,国内产品是少有的处于垄断地位的行业。 今天的主角,正处于招股期的<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a> 即是此领域的重磅玩家。 人工心脏瓣膜,医疗器械界的“网红” 每个人的心脏都有四个瓣膜,分别是主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣,正常运作的瓣膜可以确保适当的血液流动,而当其中的一个或多个瓣膜出现损伤或缺陷的时候,如瓣膜太窄或硬化,无法正常的开启或闭合,就会造成血液反流,轻者会感到乏力、呼吸困难、眩晕,重者会引发心绞痛,血栓栓塞和心脏衰竭,是死亡率极高的病种。 目前,治疗主动脉瓣疾病的方案主要是传统的开胸手术,手术切口在18cm左右,不仅复杂和费用高昂,术后并发症也较为严重,一般只有到了危重期才会采用。 到了2002年,经导管主动脉瓣置换术(TAVR)在法国进行了首次治疗,其无需开胸、通过血管路径植入人工心脏瓣膜,不仅创伤小,而且恢复快,迅速成为新一代治疗方案,引得诸多国际大厂争相涌入,人工心脏瓣膜迅速成为医疗器械界的“网红”。 (人工主动脉瓣说明图) 在国际上,爱德华兹和美敦力占据了市场的主要份额。在国内,抢先一步上市的启明医疗占据了主要的份额,根据招股书披露,2018年,启明医","text":"本周五上市的生物科技热门股$沛嘉医疗-B(09996)$高开74.48%,现在上车晚不晚? 对于医疗器械,大家并不陌生,小到体温计、血压仪,大到呼吸机、核磁共振器,医疗器械成为人类生命健康不可或缺的产业。 而高端医疗器械更是集合了生物工程、电子信息和医学影像等高新技术,是知识密集型、资金密集型的战略新兴产业。 目前,我国的高端医疗器械市场大部分仍被外资垄断,但在经导管瓣膜治疗领域,国内产品是少有的处于垄断地位的行业。 今天的主角,正处于招股期的$沛嘉医疗-B(09996)$ 即是此领域的重磅玩家。 人工心脏瓣膜,医疗器械界的“网红” 每个人的心脏都有四个瓣膜,分别是主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣,正常运作的瓣膜可以确保适当的血液流动,而当其中的一个或多个瓣膜出现损伤或缺陷的时候,如瓣膜太窄或硬化,无法正常的开启或闭合,就会造成血液反流,轻者会感到乏力、呼吸困难、眩晕,重者会引发心绞痛,血栓栓塞和心脏衰竭,是死亡率极高的病种。 目前,治疗主动脉瓣疾病的方案主要是传统的开胸手术,手术切口在18cm左右,不仅复杂和费用高昂,术后并发症也较为严重,一般只有到了危重期才会采用。 到了2002年,经导管主动脉瓣置换术(TAVR)在法国进行了首次治疗,其无需开胸、通过血管路径植入人工心脏瓣膜,不仅创伤小,而且恢复快,迅速成为新一代治疗方案,引得诸多国际大厂争相涌入,人工心脏瓣膜迅速成为医疗器械界的“网红”。 (人工主动脉瓣说明图) 在国际上,爱德华兹和美敦力占据了市场的主要份额。在国内,抢先一步上市的启明医疗占据了主要的份额,根据招股书披露,2018年,启明医","images":[{"img":"https://static.tigerbbs.com/18b57aa7c2044247e78d21a3dcc45c5a","width":"927","height":"347"},{"img":"https://static.tigerbbs.com/409cce658000fd1c44108a05914ccf10","width":"860","height":"740"},{"img":"https://static.tigerbbs.com/e3617049aee95ddfe2f316c0b70f46bd","width":"1126","height":"599"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/927391874","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":9,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1560,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":922845445,"gmtCreate":1587519788387,"gmtModify":1704364557936,"author":{"id":"3516231728412349","authorId":"3516231728412349","name":"TasteB","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3516231728412349","idStr":"3516231728412349"},"themes":[],"htmlText":"A and B","listText":"A and B","text":"A and B","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/922845445","isVote":1,"tweetType":1,"viewCount":946,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":922845445,"gmtCreate":1587519788387,"gmtModify":1704364557936,"author":{"id":"3516231728412349","authorId":"3516231728412349","name":"TasteB","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516231728412349","authorIdStr":"3516231728412349"},"themes":[],"htmlText":"A and B","listText":"A and B","text":"A and B","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/922845445","isVote":1,"tweetType":1,"viewCount":946,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":927398930,"gmtCreate":1588736502120,"gmtModify":1704178222420,"author":{"id":"3516231728412349","authorId":"3516231728412349","name":"TasteB","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516231728412349","authorIdStr":"3516231728412349"},"themes":[],"htmlText":"高","listText":"高","text":"高","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/927398930","repostId":"927391874","repostType":1,"repost":{"id":927391874,"gmtCreate":1588736312783,"gmtModify":1704178221726,"author":{"id":"21347731130544","authorId":"21347731130544","name":"价值投资为王","avatar":"https://static.tigerbbs.com/89ffffc59ff9ac9cb9cb74f596418d44","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"21347731130544","authorIdStr":"21347731130544"},"themes":[],"title":"沛嘉医疗:镶在高端医疗器械桂冠上的明珠","htmlText":"本周五上市的生物科技热门股<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a>高开74.48%,现在上车晚不晚? 对于医疗器械,大家并不陌生,小到体温计、血压仪,大到呼吸机、核磁共振器,医疗器械成为人类生命健康不可或缺的产业。 而高端医疗器械更是集合了生物工程、电子信息和医学影像等高新技术,是知识密集型、资金密集型的战略新兴产业。 目前,我国的高端医疗器械市场大部分仍被外资垄断,但在经导管瓣膜治疗领域,国内产品是少有的处于垄断地位的行业。 今天的主角,正处于招股期的<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a> 即是此领域的重磅玩家。 人工心脏瓣膜,医疗器械界的“网红” 每个人的心脏都有四个瓣膜,分别是主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣,正常运作的瓣膜可以确保适当的血液流动,而当其中的一个或多个瓣膜出现损伤或缺陷的时候,如瓣膜太窄或硬化,无法正常的开启或闭合,就会造成血液反流,轻者会感到乏力、呼吸困难、眩晕,重者会引发心绞痛,血栓栓塞和心脏衰竭,是死亡率极高的病种。 目前,治疗主动脉瓣疾病的方案主要是传统的开胸手术,手术切口在18cm左右,不仅复杂和费用高昂,术后并发症也较为严重,一般只有到了危重期才会采用。 到了2002年,经导管主动脉瓣置换术(TAVR)在法国进行了首次治疗,其无需开胸、通过血管路径植入人工心脏瓣膜,不仅创伤小,而且恢复快,迅速成为新一代治疗方案,引得诸多国际大厂争相涌入,人工心脏瓣膜迅速成为医疗器械界的“网红”。 (人工主动脉瓣说明图) 在国际上,爱德华兹和美敦力占据了市场的主要份额。在国内,抢先一步上市的启明医疗占据了主要的份额,根据招股书披露,2018年,启明医","listText":"本周五上市的生物科技热门股<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a>高开74.48%,现在上车晚不晚? 对于医疗器械,大家并不陌生,小到体温计、血压仪,大到呼吸机、核磁共振器,医疗器械成为人类生命健康不可或缺的产业。 而高端医疗器械更是集合了生物工程、电子信息和医学影像等高新技术,是知识密集型、资金密集型的战略新兴产业。 目前,我国的高端医疗器械市场大部分仍被外资垄断,但在经导管瓣膜治疗领域,国内产品是少有的处于垄断地位的行业。 今天的主角,正处于招股期的<a target=\"_blank\" href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a> 即是此领域的重磅玩家。 人工心脏瓣膜,医疗器械界的“网红” 每个人的心脏都有四个瓣膜,分别是主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣,正常运作的瓣膜可以确保适当的血液流动,而当其中的一个或多个瓣膜出现损伤或缺陷的时候,如瓣膜太窄或硬化,无法正常的开启或闭合,就会造成血液反流,轻者会感到乏力、呼吸困难、眩晕,重者会引发心绞痛,血栓栓塞和心脏衰竭,是死亡率极高的病种。 目前,治疗主动脉瓣疾病的方案主要是传统的开胸手术,手术切口在18cm左右,不仅复杂和费用高昂,术后并发症也较为严重,一般只有到了危重期才会采用。 到了2002年,经导管主动脉瓣置换术(TAVR)在法国进行了首次治疗,其无需开胸、通过血管路径植入人工心脏瓣膜,不仅创伤小,而且恢复快,迅速成为新一代治疗方案,引得诸多国际大厂争相涌入,人工心脏瓣膜迅速成为医疗器械界的“网红”。 (人工主动脉瓣说明图) 在国际上,爱德华兹和美敦力占据了市场的主要份额。在国内,抢先一步上市的启明医疗占据了主要的份额,根据招股书披露,2018年,启明医","text":"本周五上市的生物科技热门股$沛嘉医疗-B(09996)$高开74.48%,现在上车晚不晚? 对于医疗器械,大家并不陌生,小到体温计、血压仪,大到呼吸机、核磁共振器,医疗器械成为人类生命健康不可或缺的产业。 而高端医疗器械更是集合了生物工程、电子信息和医学影像等高新技术,是知识密集型、资金密集型的战略新兴产业。 目前,我国的高端医疗器械市场大部分仍被外资垄断,但在经导管瓣膜治疗领域,国内产品是少有的处于垄断地位的行业。 今天的主角,正处于招股期的$沛嘉医疗-B(09996)$ 即是此领域的重磅玩家。 人工心脏瓣膜,医疗器械界的“网红” 每个人的心脏都有四个瓣膜,分别是主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣,正常运作的瓣膜可以确保适当的血液流动,而当其中的一个或多个瓣膜出现损伤或缺陷的时候,如瓣膜太窄或硬化,无法正常的开启或闭合,就会造成血液反流,轻者会感到乏力、呼吸困难、眩晕,重者会引发心绞痛,血栓栓塞和心脏衰竭,是死亡率极高的病种。 目前,治疗主动脉瓣疾病的方案主要是传统的开胸手术,手术切口在18cm左右,不仅复杂和费用高昂,术后并发症也较为严重,一般只有到了危重期才会采用。 到了2002年,经导管主动脉瓣置换术(TAVR)在法国进行了首次治疗,其无需开胸、通过血管路径植入人工心脏瓣膜,不仅创伤小,而且恢复快,迅速成为新一代治疗方案,引得诸多国际大厂争相涌入,人工心脏瓣膜迅速成为医疗器械界的“网红”。 (人工主动脉瓣说明图) 在国际上,爱德华兹和美敦力占据了市场的主要份额。在国内,抢先一步上市的启明医疗占据了主要的份额,根据招股书披露,2018年,启明医","images":[{"img":"https://static.tigerbbs.com/18b57aa7c2044247e78d21a3dcc45c5a","width":"927","height":"347"},{"img":"https://static.tigerbbs.com/409cce658000fd1c44108a05914ccf10","width":"860","height":"740"},{"img":"https://static.tigerbbs.com/e3617049aee95ddfe2f316c0b70f46bd","width":"1126","height":"599"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/927391874","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":9,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1560,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}